Chris Takimoto

Director/Board Member at ALX ONCOLOGY HOLDINGS INC.

Net worth: - $ as of 31/05/2026

67 year

Health Technology

Consumer Services

Profile

Chris H.
Takimoto is currently an Independent Director at ALX Oncology Holdings, Inc. since 2025 and Global Chief Medical Officer at The Start Center For Cancer Research.
Former roles include Chief Medical Officer at IGM Biosciences, Inc. from 2021 to 2024, Senior Vice President-Oncology at Gilead Sciences, Inc. from 2020 to 2021, Chief Medical Officer at Forty Seven LLC from 2016 to 2020, VP-Experimental Medicine Early Development at Janssen Global Services LLC from 2010 to 2016, Senior Director-Translational Medicine at Ortho Biotech Oncology Research & Development from 2008 to 2010, and Associate Professor at the University of Texas Health Science Center At San Antonio.
Education includes undergraduate studies at Stanford University and doctorate degrees from Yale University and Yale School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALX ONCOLOGY HOLDINGS, INC. -.--%	31/03/2026	0 ( -.--% )	- $	31/05/2026

Chris Takimoto active positions

Companies	Position	Start
ALX ONCOLOGY HOLDINGS INC.	Director/Board Member	21/01/2025

All active positions of Chris Takimoto

Former positions of Chris Takimoto

Companies	Position	End
IGM BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	01/10/2024
GILEAD SCIENCES, INC.	Corporate Officer/Principal	01/07/2021
FORTY SEVEN, INC.	Chief Tech/Sci/R&D Officer	01/04/2020
Janssen Global Services LLC Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare	Corporate Officer/Principal	01/01/2016
Ortho Biotech Oncology Research & Development	Corporate Officer/Principal	01/01/2010

See the detail of Chris Takimoto's experience

Training of Chris Takimoto

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Takimoto's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Gilead Sciences, Inc. Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases	Health Technology
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Forty Seven, Inc. Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment	Health Technology
Janssen Global Services LLC Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare	Health Technology
Yale School of Medicine Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
IGM Biosciences, Inc. IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients	Health Technology
Ortho Biotech Oncology Research & Development
University of Texas Health Science Center At San Antonio University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ALX Oncology Holdings, Inc. ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer	Health Technology